Streetbeat News

ELTP

Elite Pharmaceuticals, Inc.

Employees

Industry

Pharmaceutical Preparation Manufacturing

Open

0.53

Mkt cap

556M

Volume

High

0.53

P/E Ratio

26.00

52-wk high

0.75

Low

0.52

Div yield

N/A

52-wk low

0.12

Elite Pharmaceuticals, Inc. reported a 33% increase in revenues for the second quarter of fiscal year 2025, ending September 30, 2024, with total revenues of $18.9 million. A conference call is scheduled for November 15, 2024, to discuss these results.

Portfolio Pulse from

November 14, 2024 | 9:45 pm

Elite Pharmaceuticals, Inc. will release its second quarter financial results for fiscal year 2025 on November 14, 2024, and will host a conference call on November 15, 2024, to discuss these results and provide a corporate update.

Portfolio Pulse from

November 07, 2024 | 12:15 pm

Elite Pharmaceuticals (OTC:ELTP) reported a 17.03% increase in Q1 sales, up from $7.67 million to $8.98 million YoY.

Portfolio Pulse from mahesh@benzinga.com

August 14, 2023 | 8:57 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.